Praxis Precision Medicines, Inc. — Director's Dealing 2021

Jul 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Praxis Precision Medicines, Inc. (PRAX)
CIK: 0001689548
Period of Report: 2021-05-13

Reporting Person: YOUNG WILLIAM D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-13	Common Stock	J	28473	—	Acquired	28473	Direct

Footnotes

F1: Pro rata distribution from Clarus Lifesciences III, L.P., of which the reporting person is a limited partner.